AMGEN and MD Anderson Cancer Center announced a research collaborative agreement focusing on Amgen's bispecific T cell engager antibody constructs, an immunotherapy that serves as a bridge between T cells and cancer cells.
A. EUGENE WASHINGTON was named chancellor for health affairs at Duke University, as well as president and chief executive officer of the Duke University Health System, effective April 1.
ST. JUDE CHILDREN'S RESEARCH HOSPITAL received a pledge of $2 million over the next 10 years from InfinityQS International Inc.
NIPUN MERCHANT is joining the Sylvester Comprehensive Cancer Center as chief surgical officer and director of Surgical Oncology Research Programs.
SHARMILA MAKHIJA was named professor and chair of the Department of Obstetrics & Gynecology and Women's Health at Albert Einstein College of Medicine and Montefiore Health System, effective April 1.
DONALD “SKIP” TRUMP was named the first CEO and executive director of the newly created Inova Cancer Care and Research Institute, part of the Inova Health System.
NCI DIRECTOR HAROLD VARMUS, in a new year's message to NCI staff and grantees, outlined the NCI's goals and obstacles for 2015 as the institute pursues new trials in precision medicine.
DARIO ALTIERI was named CEO of The Wistar Institute, following the announced retirement of President and CEO Russel Kaufman, effective March 2. Altieri will continue to serve as director of the Wistar Cancer Center, and Kaufman will become president emeritus.
FABIEN CALVO was named chief scientific officer of Cancer Core Europe.
CANCER TREATMENT CENTERS OF AMERICA selected WIRB-Copernicus Group to help expand its clinical research program. WCG will assist CTCA in the centralization of its regulatory and ethical review process.
